Central Glass (4044) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
21 Oct, 2026Executive summary
Six-month net sales fell 2.4% year over year to ¥66,430 million despite proactive sales efforts.
Operating profit declined 47.3% to ¥2,502 million as lower electrolyte sales, higher costs and LCM effects weighed on results.
Profit attributable to owners of parent fell 23.2% to ¥2,135 million; comprehensive income declined 23.5% to ¥3,595 million.
Financial highlights
Ordinary profit decreased 34.0% to ¥3,412 million; gross profit was ¥16,495 million, down from ¥18,897 million.
Basic earnings per share were ¥86.17, compared with ¥112.28 in the prior year.
Prior-year extraordinary losses from sales of affiliated companies did not recur, partly cushioning the decline in profit attributable to owners.
Outlook and guidance
FY2025 net sales guidance was cut ¥2.6bn to ¥142.4bn, operating profit ¥0.5bn to ¥7.0bn, and ordinary profit ¥0.2bn to ¥7.8bn; net income guidance remains ¥5.5bn.
Electrolyte sales are expected to recover gradually in H2, but volumes are forecast to remain significantly below the initial plan.
Net income guidance includes a planned loss on transfer of UK subsidiary shares and planned sales of listed cross-shareholdings.
FY2025 segment forecasts: Electronic Materials sales ¥24.8bn / operating profit ¥3.0bn; Energy Materials ¥12.1bn / loss ¥3.0bn; Glass ¥59.2bn / profit ¥1.9bn.
Full-year EPS is forecast at ¥221.90.
Latest events from Central Glass
- New semiconductor materials support a ¥470億 FY2030 sales target.4044
Investor update - Higher H1 sales masked sharp profit declines, prompting lower FY2023 guidance.4044
Q2 2023 - Sales growth was offset by lower operating profit and net income.4044
Q1 2023 - FY2023 beat profit forecasts, but FY2024 earnings are expected to retreat.4044
Q4 2023 - Stronger glass sales could not offset lower chemical earnings and reduced extraordinary income.4044
Q3 2023 - Sales fell 10.7%, but operating profit rose on LCM support; FY guidance was unchanged.4044
Q1 2024 - Weak demand cut nine-month results and FY2024 forecasts; the ¥170 dividend was maintained.4044
Q3 2024 - H1 earnings fell on weaker demand and a share-sale loss; FY guidance was unchanged.4044
Q2 2024 - FY2025 sales edge higher, but operating profit falls amid weak demand and tariffs.4044
Q4 2024